An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.
about
Along the Axis between Type 1 and Type 2 Immunity; Principles Conserved in Evolution from Fish to MammalsA potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chainsNovel therapy for asthma.New approaches in the treatment of asthma.Scintillation proximity assay in lead discovery.New therapeutics that modulate chemokine networks.Antiasthmatic effects of hesperidin, a potential Th2 cytokine antagonist, in a mouse model of allergic asthmaAntiasthmatic Effects of Herbal Complex MA and Its Fermented Product MA128.Pinellia ternata, Citrus reticulata, and their combinational prescription inhibit eosinophil infiltration and airway hyperresponsiveness by suppressing CCR3+ and Th2 cytokines production in the ovalbumin-induced asthma model.Effects of Inhalable Microparticles of Seonpyejeongcheon-Tang in an Asthma Mouse Model: - Effects of Microparticles of SJT.Cytokine mediated suppression of TF-1 apoptosis requires PI3K activation and inhibition of Bim expression.Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis.Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model.IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation.The cell surface expression level of the human interleukin-5 receptor alpha subunit determines the agonistic/antagonistic balance of the human interleukin-5 E13Q mutein.New biological therapies from the human genome.Spatial Orientation of the α and βcReceptor Chain Binding Sites on Monomeric Human Interleukin-5 ConstructsCytokines: Principles and prospectsImmunological and hematological effects of IL-5(Rα)-targeted therapy: An overview
P2860
Q28083360-F68D4A5E-E28C-4AF1-B57B-D29082EABFD7Q30872919-A62D91A1-2D8F-48DE-B6E3-702E3E06E639Q34074657-39E2D27A-90EE-40AD-8C0C-EFB5B4717ADBQ34192933-F284F666-9E56-4670-9D80-F41484D2F1C9Q34621362-4003CC11-A391-442F-9466-762428ACAA1BQ34743328-CFEFA236-DA88-4FC4-AAC0-44A0338E62A4Q35104538-F751D489-7C12-4FD7-AB8A-820F6C525F02Q35607608-0D6381A8-FE1E-4693-8E69-DFFC1DC25EB2Q37286252-F1A0B361-5BE2-43C4-84B1-85BC0F68448FQ37585203-B265ADD2-C7DD-4850-BF41-79CA00AFAAC2Q40476852-565CE280-D17D-4070-B989-9FD21BCDD425Q44444385-F2D9301C-0829-4E5F-A728-6CE48C325A60Q46119498-B6CDD1FE-4AD8-4836-BCA9-59195C174019Q48014771-57C86F27-FB54-42C5-8D93-2D34F46B2B3BQ49085328-2EBB5FD5-C403-4933-A064-7E4A672D08EBQ51016737-B22503FB-58AA-47C0-90DA-43E1C27439B3Q57019220-868EFD7B-072C-41F6-9CFA-5B99BED5186CQ57240716-DD1D184A-AE0F-47FD-A340-07BF7519056EQ58693435-CEF86EF0-BCE4-4784-995A-D8A78FBF67A1
P2860
An interleukin 5 mutant distinguishes between two functional responses in human eosinophils.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
An interleukin 5 mutant distin ...... esponses in human eosinophils.
@en
An interleukin 5 mutant distin ...... esponses in human eosinophils.
@nl
type
label
An interleukin 5 mutant distin ...... esponses in human eosinophils.
@en
An interleukin 5 mutant distin ...... esponses in human eosinophils.
@nl
prefLabel
An interleukin 5 mutant distin ...... esponses in human eosinophils.
@en
An interleukin 5 mutant distin ...... esponses in human eosinophils.
@nl
P2093
P2860
P356
P1476
An interleukin 5 mutant distin ...... responses in human eosinophils
@en
P2093
A E Proudfoot
M McKinnon
P2860
P304
P356
10.1084/JEM.186.1.121
P407
P577
1997-07-01T00:00:00Z